LONDON and RALEIGH, N.C., April 25, 2023 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the first quarter ended March 31, 2023 on Tuesday, May 9, 2023 and…Read More
Verona Pharma to Report First Quarter 2023 Financial Results and Provide Corporate Update
